Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus

Primary treatment for patients with intermittent claudication is exercise therapy. Diabetes mellitus (DM) is a frequently occurring comorbidity in patients with intermittent claudication, and in these patients, exercise tolerance is decreased. However, there is little literature about the increase i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of vascular surgery Jg. 26; H. 7; S. 957
Hauptverfasser: van Pul, Kim M, Kruidenier, Lotte M, Nicolaï, Saskia P A, de Bie, Rob A, Nieman, Fred H M, Prins, Martin H, Teijink, Joep A W
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands 01.10.2012
Schlagworte:
ISSN:1615-5947, 1615-5947
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Primary treatment for patients with intermittent claudication is exercise therapy. Diabetes mellitus (DM) is a frequently occurring comorbidity in patients with intermittent claudication, and in these patients, exercise tolerance is decreased. However, there is little literature about the increase in walking distance after supervised exercise therapy (SET) in patients with both intermittent claudication and DM. The objective of this study was to determine the effectiveness of SET for intermittent claudication in patients with DM. Consecutive patients with intermittent claudication who started SET were included. Exclusion criteria were Rutherford stage 4 to 6 and the inability to perform the standardized treadmill test. SET was administered according to the guidelines of the Royal Dutch Society for Physiotherapy. At baseline and at 1, 3, and 6 months of follow-up, a standardized treadmill exercise test was performed. The primary outcome measurement was the absolute claudication distance (ACD). We included 775 patients, of whom 230 had DM (29.7%). At 6 months of follow-up, data of 440 patients were available. Both ACD at baseline and at 6 months of follow-up were significantly lower in patients with DM (P < 0.001). However, increase in ACD after 6 months of SET did not differ significantly (P = 0.48) between the DM group and the non-DM group (270 m and 400 m, respectively). In conclusion, SET for patients with intermittent claudication is equally effective in improving walking distance for both patients with and without DM, although ACD remains lower in patients with DM.
AbstractList Primary treatment for patients with intermittent claudication is exercise therapy. Diabetes mellitus (DM) is a frequently occurring comorbidity in patients with intermittent claudication, and in these patients, exercise tolerance is decreased. However, there is little literature about the increase in walking distance after supervised exercise therapy (SET) in patients with both intermittent claudication and DM. The objective of this study was to determine the effectiveness of SET for intermittent claudication in patients with DM.BACKGROUNDPrimary treatment for patients with intermittent claudication is exercise therapy. Diabetes mellitus (DM) is a frequently occurring comorbidity in patients with intermittent claudication, and in these patients, exercise tolerance is decreased. However, there is little literature about the increase in walking distance after supervised exercise therapy (SET) in patients with both intermittent claudication and DM. The objective of this study was to determine the effectiveness of SET for intermittent claudication in patients with DM.Consecutive patients with intermittent claudication who started SET were included. Exclusion criteria were Rutherford stage 4 to 6 and the inability to perform the standardized treadmill test. SET was administered according to the guidelines of the Royal Dutch Society for Physiotherapy. At baseline and at 1, 3, and 6 months of follow-up, a standardized treadmill exercise test was performed. The primary outcome measurement was the absolute claudication distance (ACD).METHODSConsecutive patients with intermittent claudication who started SET were included. Exclusion criteria were Rutherford stage 4 to 6 and the inability to perform the standardized treadmill test. SET was administered according to the guidelines of the Royal Dutch Society for Physiotherapy. At baseline and at 1, 3, and 6 months of follow-up, a standardized treadmill exercise test was performed. The primary outcome measurement was the absolute claudication distance (ACD).We included 775 patients, of whom 230 had DM (29.7%). At 6 months of follow-up, data of 440 patients were available. Both ACD at baseline and at 6 months of follow-up were significantly lower in patients with DM (P < 0.001). However, increase in ACD after 6 months of SET did not differ significantly (P = 0.48) between the DM group and the non-DM group (270 m and 400 m, respectively).RESULTSWe included 775 patients, of whom 230 had DM (29.7%). At 6 months of follow-up, data of 440 patients were available. Both ACD at baseline and at 6 months of follow-up were significantly lower in patients with DM (P < 0.001). However, increase in ACD after 6 months of SET did not differ significantly (P = 0.48) between the DM group and the non-DM group (270 m and 400 m, respectively).In conclusion, SET for patients with intermittent claudication is equally effective in improving walking distance for both patients with and without DM, although ACD remains lower in patients with DM.CONCLUSIONIn conclusion, SET for patients with intermittent claudication is equally effective in improving walking distance for both patients with and without DM, although ACD remains lower in patients with DM.
Primary treatment for patients with intermittent claudication is exercise therapy. Diabetes mellitus (DM) is a frequently occurring comorbidity in patients with intermittent claudication, and in these patients, exercise tolerance is decreased. However, there is little literature about the increase in walking distance after supervised exercise therapy (SET) in patients with both intermittent claudication and DM. The objective of this study was to determine the effectiveness of SET for intermittent claudication in patients with DM. Consecutive patients with intermittent claudication who started SET were included. Exclusion criteria were Rutherford stage 4 to 6 and the inability to perform the standardized treadmill test. SET was administered according to the guidelines of the Royal Dutch Society for Physiotherapy. At baseline and at 1, 3, and 6 months of follow-up, a standardized treadmill exercise test was performed. The primary outcome measurement was the absolute claudication distance (ACD). We included 775 patients, of whom 230 had DM (29.7%). At 6 months of follow-up, data of 440 patients were available. Both ACD at baseline and at 6 months of follow-up were significantly lower in patients with DM (P < 0.001). However, increase in ACD after 6 months of SET did not differ significantly (P = 0.48) between the DM group and the non-DM group (270 m and 400 m, respectively). In conclusion, SET for patients with intermittent claudication is equally effective in improving walking distance for both patients with and without DM, although ACD remains lower in patients with DM.
Author Teijink, Joep A W
de Bie, Rob A
Prins, Martin H
Nicolaï, Saskia P A
van Pul, Kim M
Nieman, Fred H M
Kruidenier, Lotte M
Author_xml – sequence: 1
  givenname: Kim M
  surname: van Pul
  fullname: van Pul, Kim M
  organization: Department of Surgery, Atrium Medical Center Parkstad, Heerlen, The Netherlands
– sequence: 2
  givenname: Lotte M
  surname: Kruidenier
  fullname: Kruidenier, Lotte M
– sequence: 3
  givenname: Saskia P A
  surname: Nicolaï
  fullname: Nicolaï, Saskia P A
– sequence: 4
  givenname: Rob A
  surname: de Bie
  fullname: de Bie, Rob A
– sequence: 5
  givenname: Fred H M
  surname: Nieman
  fullname: Nieman, Fred H M
– sequence: 6
  givenname: Martin H
  surname: Prins
  fullname: Prins, Martin H
– sequence: 7
  givenname: Joep A W
  surname: Teijink
  fullname: Teijink, Joep A W
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22858162$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtKxDAUhoMozkVfwIVk6aY1SdMkXcowXmDAja5Lmpw4GaYXm3R03t6AI7g6H-d8HH7-BTrv-g4QuqEkp4SK-12uD-EjZ4SynPCcEHWG5lTQMisrLs__8QwtQtiRJCquLtGMMVUqKtgcubVzYCLuHQ7TAOPBB7AYvmE0iXDcwqiHI3b9iH0XYWx9jNBFbPZ6st7o6PsuXfCQKO0D_vJxi63XDUQIuIX93scpXKELp_cBrk9zid4f12-r52zz-vSyethkhgsWM2YpWJfCScukbMqmotJYyaB0lXGNLblTpSDcOChsA1IDF7QQjivbMMYtW6K737_D2H9OEGLd-mBSCN1BP4WakkIRUVWySOrtSZ2aFmw9jL7V47H-64b9AIGEa_k
CitedBy_id crossref_primary_10_1177_1358863X16674071
crossref_primary_10_1111_1753_0407_12304
crossref_primary_10_1016_j_jvs_2023_12_008
crossref_primary_10_1016_j_avsg_2016_02_009
crossref_primary_10_1016_j_avsg_2020_03_040
crossref_primary_10_1016_j_avsg_2014_10_010
crossref_primary_10_7759_cureus_52019
crossref_primary_10_1016_j_jvs_2013_10_058
ContentType Journal Article
Copyright Copyright © 2012 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2012 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.avsg.2012.04.008
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1615-5947
ExternalDocumentID 22858162
Genre Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID ---
--K
-~C
.1-
.86
.FO
.GJ
0R~
1B1
1P~
1RT
1SB
1~5
2.D
23M
2JY
2P1
4.4
457
4G.
53G
5GY
5RE
5VS
6NX
7-5
78A
875
8TC
AAEDT
AAEDW
AAIAL
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
AAYWO
AAYZH
ABJNI
ABMAC
ABWVN
ACGFS
ACRPL
ADBBV
ADIMF
ADMUD
ADNMO
ADRFC
AENEX
AEVXI
AFCTW
AFJKZ
AFLOW
AFRHN
AFTJW
AGCQF
AGQPQ
AHACP
AHBYD
AHHHB
AHMBA
AHSBF
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BELOY
BGNMA
CAG
CGR
COF
CS3
CUY
CVF
DL5
EBS
ECM
EFKBS
EIF
EJD
F5P
FDB
FEDTE
FGOYB
G-2
HG6
HMK
HMO
HVGLF
HZ~
I09
IHE
KOV
LAS
M28
M41
M4Y
NPM
NU0
O9-
OK-
OW-
PQQKQ
QOK
QOS
R2-
R4E
RIG
ROL
RPX
RPZ
RRX
SAE
SDH
SDM
SEL
SES
SMD
SOJ
TSK
U2A
VC2
WJK
WK8
XH2
Z5R
ZGI
~EX
7X8
ID FETCH-LOGICAL-c462t-2d1edf2857d277b5b917cd72e5f9cfbd54f85604cfe3dbe7ae46136f48db224d2
IEDL.DBID 7X8
ISICitedReferencesCount 11
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000308852800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1615-5947
IngestDate Sat Sep 27 21:26:30 EDT 2025
Mon Jul 21 05:55:52 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License Copyright © 2012 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-2d1edf2857d277b5b917cd72e5f9cfbd54f85604cfe3dbe7ae46136f48db224d2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22858162
PQID 1038069973
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1038069973
pubmed_primary_22858162
PublicationCentury 2000
PublicationDate 2012-10-01
PublicationDateYYYYMMDD 2012-10-01
PublicationDate_xml – month: 10
  year: 2012
  text: 2012-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Annals of vascular surgery
PublicationTitleAlternate Ann Vasc Surg
PublicationYear 2012
SSID ssj0012848
Score 2.0289717
Snippet Primary treatment for patients with intermittent claudication is exercise therapy. Diabetes mellitus (DM) is a frequently occurring comorbidity in patients...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 957
SubjectTerms Aged
Chi-Square Distribution
Comorbidity
Diabetes Mellitus - diagnosis
Diabetes Mellitus - epidemiology
Diabetes Mellitus - physiopathology
Exercise Test
Exercise Therapy
Exercise Tolerance
Female
Humans
Intermittent Claudication - diagnosis
Intermittent Claudication - epidemiology
Intermittent Claudication - physiopathology
Intermittent Claudication - therapy
Male
Middle Aged
Netherlands - epidemiology
Predictive Value of Tests
Recovery of Function
Time Factors
Treatment Outcome
Walking
Title Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus
URI https://www.ncbi.nlm.nih.gov/pubmed/22858162
https://www.proquest.com/docview/1038069973
Volume 26
WOSCitedRecordID wos000308852800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA7qiHhxX8aNCF6D0zRp0pOIOHiZYQ4KcyvNJoK2o20H_Pe-tClzEgQvvZRCSF7f-_KW70PoRkVa-PILoYlhhNk8JoDjIiIdV4pTDUFPt2ITYjqV83k6Cwm3KrRV9j6xddSm1D5HfuuJvEdJmor4bvFJvGqUr64GCY11NIgBynirFvNVFQFcbzsKB1Gb8JSJMDTT9Xfly-rVt3bRlup0JH-HmG2oGe_-d5F7aCeATHzfWcU-WrPFAdqahDL6IXIdZzEuHa6ahfcWlTW4V1_C3UzWNwY8iz2dhJ_5B2hdY_2eNyYk-eANDqSsFfbZXNyncfGHJ_msm-oIvYwfnx-eSBBcIJoltCbURNY4KrkwVAjFFdzltBHUcpdqpwxnTgJCYtrZ2CgrcssADSSOSaMAChh6jDaKsrCnCDvOYwNYmEsFVzbjAGjk0jDLcqvEKKVDdN3vYAYG7asUeWHLpspWezhEJ90xZIuOeSOjsDYZJfTsD1-fo21_ul3j3QUaOPid7SXa1Mv6rfq6ai0FntPZ5Aelncq8
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+supervised+exercise+therapy+for+intermittent+claudication+in+patients+with+diabetes+mellitus&rft.jtitle=Annals+of+vascular+surgery&rft.au=van+Pul%2C+Kim+M&rft.au=Kruidenier%2C+Lotte+M&rft.au=Nicola%C3%AF%2C+Saskia+P+A&rft.au=de+Bie%2C+Rob+A&rft.date=2012-10-01&rft.issn=1615-5947&rft.eissn=1615-5947&rft.volume=26&rft.issue=7&rft.spage=957&rft_id=info:doi/10.1016%2Fj.avsg.2012.04.008&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1615-5947&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1615-5947&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1615-5947&client=summon